Skip to main navigation Skip to search Skip to main content

Impact of different extracorporeal blood purification strategies during continuous renal replacement therapy in septic shock patients

  • Pedja Kovacevic
  • , Nikolina Spiric
  • , Katarina Vucicevic
  • , Sasa Dragic
  • , Danica Momcicevic
  • , Biljana Zlojutro
  • , Milka Jandric
  • , Tijana Kovacevic
  • , Jihad Mallat
  • University Clinical Centre Republic of Srpska
  • University of Banja Luka
  • University of Belgrade
  • Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Research output: Contribution to journalArticlepeer-review

Abstract

BackgroundSeptic shock with acute kidney injury is associated with high mortality. Hemoadsorption methods such as CytoSorbⓇ in conjunction with standard continuous renal replacement therapy (CRRT) and oXirisⓇ-based CRRT are increasingly used; however, comparative data are scarce. This study assessed the effects of both filters on vasopressor-free days and key clinical outcomes in septic shock.MethodsThis retrospective single-center cohort included adults with septic shock treated with CytoSorbⓇ in conjunction with CRRT or oXirisⓇ-based CRRT between January 2023 and December 2024. The primary endpoint was vasopressor-free days to day 28, with secondary outcomes including Sequential Organ Failure Assessment (SOFA) score, lactate levels, norepinephrine equivalent dose (NEED), mean arterial pressure, ventilator-free days, intensive care unit (ICU) length of stay, and mortality.ResultsA total of 97 patients were included in the analysis. (CytoSorbⓇ n=75; oXirisⓇ n=22). Both extracorporeal blood purification modalities were associated with comparable reductions in lactate levels (median [IQR]: −39.7 [−47.2 to −19.3]% vs. 44.5 [−54.0 to −33.3] %, respectively, P=0.14), and NEED (median [IQR]: −36.1 [−66.7 to −9.1] vs. −56.4 [−83.3 to −12.5] %, respectively, P=0.36), along with similar increases in mean arterial pressure (9.6 [7.7–18.2]% vs. 9.8 [7.7–16.7] %, respectively, P=0.94). No significant differences were found between the two modalities. Vasopressor-free days were similar (median [IQR]: 0.0 [0–24] days with CytoSorbⓇ vs. 20.5 [0–25] days with oXirisⓇ, P=0.55). In the multivariable competing-risks analysis, extracorporeal blood purification modality was not independently associated with vasopressor-free days after adjustment for potential confounders (subhazard ratio [sHR]=0.97, 95% confidence interval: 0.48–1.94, P=0.93). Ventilator-free days, ICU stay, and ICU and hospital mortality were likewise comparable.ConclusionsCytoSorbⓇ in addition with CRRT and oXirisⓇ-based CRRT demonstrated similar hemodynamic and clinical outcomes. Larger prospective studies are needed to define the optimal role of extracorporeal CRRT-based blood purification in septic shock.

Original languageEnglish
JournalJournal of Intensive Medicine
DOIs
StateAccepted/In press - 2026

Keywords

  • Clinical outcome
  • Continuous renal replacement therapy
  • CytoSorbⓇ
  • Extracorporeal blood purification
  • Hemoadsorption
  • Intensive care unit
  • Septic shock
  • Vasopressor-free days
  • oXirisⓇ

Fingerprint

Dive into the research topics of 'Impact of different extracorporeal blood purification strategies during continuous renal replacement therapy in septic shock patients'. Together they form a unique fingerprint.

Cite this